20 LATEST RESOURCES (1110 INDEXED)
Impacts of Metabolic Disruption, Body Mass Index and Inflammation on Cognitive Function in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine · February 2024
Articles
Annals of General Psychiatry
ADHD Medications Use and Risk of Mortality and Unintentional Injuries: A Population-Based Cohort Study · February 2024
Articles
Translational Psychiatry
An Emergency-Department-Initiated Outreach Program for Patients with Opioid Use Disorder Is Associated with an Increase in Agonist Therapy and Engagement in Addictions Care: A One-Year Cohort Study · February 2024
Articles
Substance Abuse Treatment, Prevention, and Policy
Factors Associated with Frequent Buprenorphine / Naloxone Initiation in a National Survey of Canadian Emergency Physicians · February 2024
Articles
PLOS ONE
A Computational Model to Characterize the Time-Course of Response to Rapid Antidepressant Therapies · February 2024
Articles
PLOS ONE
Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-Compulsive Disorder · August 2023
Articles
Clinical Psychopharmacology and Neuroscience
Buprenorphine Deregulation as an Opioid Crisis Policy Response – A Comparative Analysis between France and the United States · August 2023
Articles
International Journal of Drug Policy
Trends in Delirium and New Antipsychotic and Benzodiazepine Use among Hospitalized Older Adults Before and After the Onset of the COVID-19 Pandemic · August 2023
Articles
JAMA Network Open
Continuity of Care among Patients Newly Initiated on Second-Generation Oral or Long-Acting Injectable Antipsychotics during a Schizophrenia-Related Inpatient Stay · July 2023
Articles
Current Medical Research and Opinion
Brexpiprazole versus Placebo or Other Antidepressive Agents for Treating Depression · July 2023
Abstracts
Cochrane Database of Systematic Reviews
Absolute and Relative Risks of Kidney Outcomes Associated with Lithium vs Valproate Use in Sweden · July 2023
Articles
JAMA Network Open
Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021 · July 2023
Articles
JAMA Network Open
Impacts of Antipsychotic Medication Prescribing Practices in Critically Ill Adult Patients on Health Resource Utilization and New Psychoactive Medication Prescriptions · June 2023
Articles
PLOS ONE
Adverse Events with Quetiapine and Clarithromycin Coprescription: A Population-Based Retrospective Cohort Study · June 2023
Articles
Health Science Reports
Associations of Methadone and Buprenorphine-Naloxone Doses with Unregulated Opioid Use, Treatment Retention, and Adverse Events in Prescription-Type Opioid Use Disorders: Exploratory Analyses of the OPTIMA Study · June 2023
Articles
American Journal on Addictions
The Four-Factor Personality Model and Its Qualitative Correlates among Opioid Agonist Therapy Clients · June 2023
Articles
Frontiers in Psychiatry
Informing Youth-Centred Opioid Agonist Treatment: Findings from a Retrospective Chart Review of Youths’ Characteristics and Patterns of Opioid Agonist Treatment Engagement in a Novel Integrated Youth Services Program · May 2023
Articles
Early Intervention in Psychiatry
Infant Exposure to Fluvoxamine through Placenta and Human Milk: A Case Series – A Contribution from the ConcePTION Project · May 2023
Articles
Frontiers in Psychiatry
Multi-Omic Modeling of Antidepressant Response Implicates Dynamic Immune and Inflammatory Changes in Individuals Who Respond to Treatment · May 2023
Articles
PLOS ONE
Adherence to Antipsychotic Laboratory Monitoring Guidelines in Children and Youth: A Population-Based Study · May 2023
Articles
Frontiers in Psychiatry